SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-23-209157
Filing Date
2023-08-10
Accepted
2023-08-10 17:01:56
Documents
6

Document Format Files

Seq Description Document Type Size
1 S-3 d525932ds3.htm S-3 436227
2 EX-5.1 d525932dex51.htm EX-5.1 66377
3 EX-23.1 d525932dex231.htm EX-23.1 1700
4 EX-FILING FEES d525932dexfilingfees.htm EX-FILING FEES 22138
5 GRAPHIC g525932g0329102329863.jpg GRAPHIC 2648
6 GRAPHIC g525932g20s85.jpg GRAPHIC 38220
  Complete submission text file 0001193125-23-209157.txt   579687
Mailing Address 245 HAMMERSMITH ROAD, 3RD FLOOR LONDON X0 W6 8PW
Business Address 245 HAMMERSMITH ROAD, 3RD FLOOR LONDON X0 W6 8PW 011-44-0-203-3846700
Orchard Therapeutics plc (Filer) CIK: 0001748907 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-273891 | Film No.: 231160494
SIC: 2836 Biological Products, (No Diagnostic Substances)